亚洲 欧美 激情 小说 另类,三年片在线观看免费观看高清电影,青青河边草高清免费版新闻,xbox高清视频线

Innovation Accelerating a World Without Disease The World Without Disease Accelerator (WWDA) is a unique enterprise R&D group aligned with global commercial expertise andfocused on the discovery, development and delivery of disruptive products/technologies, business models and partnerships to advance the elimination of disease. The WWDA brings together distinct enabling capabilities in areas including the microbiome, immunosciences,predictive analytics and behavioral sciences to seed transformative growth opportunities and catalyze a paradigm shift in prevention,interception and cure strategies and solutions.

Building on the 130-year legacy of Johnson & Johnson blending heart, science and ingenuity to tackle some of today’s most pressing public health challenges, we believe that all people - no matter where they live - deserve access to lifesaving innovation at the same time.

Public HealthJOHNSON & Charting a bold, new, self-sustainable approach,Johnson & Johnson Global Public Health is pushing boundaries as the frst fully-dedicated organization within a healthcare company working to ensure that innovative treatments and technologies are available,affordable and accessible for the world’s most underserved populations.

Combining R&D, novel access programs and business model innovation, in-country operations, and the power of multi-sectoral partnerships we are committed to unlocking the power of science to move beyond incremental improvement to achieve transformational outcomes and solve for HIV, tuberculosis and other high burden diseases which disproportionately impact people in low income countri***

To achieve that we seek to partner within and outside Johnson & Johnson Family of Companies to deliver on the promise of improved health for all, everywhere.

TB Expanding access and uptake of existing regimens for multidrugresistant TB (MDR-TB), developing simplifed treatment regimens and novel molecular approaches; companion diagnostics.

Novel and simplifed treatment tools, including new formulations,point-of-care diagnostics and others; innovative prevention tools andstrategies, including vaccines, microbicides and other education/ empowerment programs.

OTHERS Nontuberculous mycobacterial lung disease (NTM); Dengue prevention and treatment; Malaria prevention and treatment; Chagas disease; Obstetric fstula repair; preterm birth prevention; maternal/newborn survival; general surgery and trauma; pandemic preparedness and emerging threats (e.g., Ebola, Zika, etc.).

Connect With Us

External Innovation Contacts

External Innovation

William N. Hait, M.D., Ph.D.

Global Head, Johnson & Johnson

External Innovation

E: jnjinnovation**[ta]**.jnj.com

Strategic Investing

Tom Heyman

President, JJDC

E: info-jjdc**[ta]**.jnj.com

Company Incubation

Melinda Richter

Global Head, JLABS

E: jlabs**[ta]**.jnj.com

Innovation Center San Francisco,

California, USA

Rowan Chapman, Ph.D.

Head, Johnson & Johnson Innovation,

West North America and Australia

E: jnjinnovation**[ta]**.jnj.com

Innovation Center Shanghai, China

Dan Wang, M.D., MBA, MPH

Head, Johnson & Johnson Innovation,

APAC (Asia Pacifc)

E: jnjinnovation**[ta]**.jnj.com

Innovation Center London, UK

Sir Harpal Kumar, Dsc, MEng, MBA

Head, Johnson & Johnson Innovation,

EMEA (Europe, Middle East and Africa)

E: jnjinnovation**[ta]**.jnj.com

Innovation Center Boston, USA

Michal Preminger, Ph.D., MBA

Head, Johnson & Johnson Innovation,

East North America

E: jnjinnovation**[ta]**.jnj.com

Lung Cancer Initiative

Avrum Spira, M.D., M.S.C.

Global Head, Lung Cancer Initiative

E: aspira**[ta]**.jnj.com

World Without Disease Accelerator

Ben Wiegand

Global Head, WWDA

E: bwiegan**[ta]**.jnj.com

Global Public Health

Jaak Peeters

Global Head, Global Public Health

E: gph**[ta]**.jnj.com

Health Technology

Oliver Hsiang

Global Head, Health Technology Partnerships

& Corporate Development

E: ohsiang**[ta]**.jnj.com

Janssen R&D Leadership Contacts

Cardiovascular & Metabolism

James F. List, M.D., Ph.D.

Global Therapeutic Head,

Cardiovascular & Metabolism

Janssen Research & Development

Mathai Mammen, M.D., Ph.D.

Global Head, Research & Development

EARLY STAGE - J&J INNOVATION

Mark Erion, Discovery

E: merion**[ta]**.jnj.com

Thomas Gustafson, West US & ANZ

E: tgustaf5**[ta]**.jnj.com

Jim Tobin, East US

E: jtobin3**[ta]**.jnj.com

Shamina Rangwala, Europe

E: srangwal**[ta]**.jnj.com

LATE STAGE - JBD

Sarah Brennan

E: sbrennan**[ta]**.jnj.com

Scott Lundeen, Scientifc Licensing

E: slundeen**[ta]**.jnj.com

Oncology

Peter Lebowitz, M.D., Ph.D.

Global Therapeutic Head, Oncology

EARLY STAGE - J&J INNOVATION

Joseph Erhardt, Discovery

E: jerhardt**[ta]**.jnj.com

Sylvaine Cases, West US & ANZ

E: scases**[ta]**.jnj.com

Bob Radinsky, East US

E: rradinsk**[ta]**.jnj.com

Sonal Patel, Eur***

E: spate203**[ta]**.jnj.com

Stefan Hart, Asia Pacifc

E: shart16**[ta]**.jnj.com

LATE STAGE - JBD

Deborah Watson

E: dwatson4**[ta]**.jnj.com

Mike Rycyzyn, Scientifc Licensing

E: mrycyzyn**[ta]**.jnj.com

Immunology

David M. Lee, M.D., Ph.D.

Global Therapeutic Head, Immunology

EARLY STAGE - J&J INNOVATION

Ian Anderson, Discovery

E: ianders7**[ta]**.jnj.com

Jackie Benson, West US & ANZ

E: jbenson4**[ta]**.jnj.com

Michael Elliott, East US

E: melliot2**[ta]**.jnj.com

LATE STAGE - JBD

Johan Verbeeck

E: jverbee2**[ta]**.jnj.com

Simon Blake, Scientifc Licensing

E: sblake5**[ta]**.jnj.com

Discovery and Platforms

Richard Tillyer, Ph.D.

Global Head, Discovery, Product Development

& Supply (DPDS)

Beth Hill

E: bhill4**[ta]**.jnj.com

Trevor Howe, Europe

E: thowe4**[ta]**.jnj.com

Julian Bertschinger

E: jbertsc**[ta]**.jnj.com

Neuroscience

Husseini K. Manji, M.D., F.R.C.P.C.

Global Therapeutic Head, Neuroscience

EARLY STAGE - J&J INNOVATION

David Bredt, Discovery

E: dbredt**[ta]**.jnj.com

Guy Seabrook, West US & AZ

E: gseabroo**[ta]**.jnj.com

Eric Schaeffer, East US

E: eschaef7**[ta]**.jnj.com

Declan Jones, Europe

E: djone119**[ta]**.jnj.com

John Issac, Europe

E: jisaac5**[ta]**.jnj.com

LATE STAGE - JBD

Lucinda Warren

E: cwarren4**[ta]**.jnj.com

Gregor Macdonald, Scientifc Licensing

E: gmacdon1**[ta]**.jnj.com

Infectious Diseases & Vaccines

James Merson, Ph.D.

Global Therapeutic Head, Infectious Diseases

Johan Van Hoof, M.D.

Global Therapeutic Head, Vaccines

EARLY STAGE - J&J INNOVATION

Debbie Law, Discovery

E: dlaw2**[ta]**.jnj.com

Kenneth Simmen, Global (Europe focused)

E: ksimmen1**[ta]**.jnj.com

Nicola La Monica, US & ANZ

E: nlamonic**[ta]**.jnj.com

LATE STAGE - JBD

Marianne De Backer

E: mdbacker**[ta]**.jnj.com

Philippe Alen, Scientifc Licensing

E: palen**[ta]**.jnj.com

Pulmonary Hypertension

Martin Fitchet, M.D.

Global Therapeutic Head, Pulmonary Hypertension

LATE STAGE - JBD

Nicolas Franco

E: nfranco9**[ta]**.jnj.com

Joerg Laeuffer, Scientifc Licensing

E: jlaeuff1**[ta]**.jnj.com

Data Science

Troy Sarich, Janssen R&D Strategy

E: tsarich**[ta]**.jnj.com

Najat Khan, Janssen R&D Strategy

E: nkhan31**[ta]**.jnj.com

Joseph Lehar, Oncology

E: jlehar**[ta]**.jnj.com

Guna Rajagopal, Genomics

E: grajagop**[ta]**.jnj.com

Vaibhav Narayan, Neuroscience

E: vnaray16**[ta]**.jnj.com

Emma Huang, J&J Innovation

E: bhuang26**[ta]**.jnj.com

Janssen Business Development

Patrick Verheyen

Global Head, Janssen Business Development

Global Public Health

Wim Parys, M.D.

Head R&D, Global Public Health

Jens Bitsch-Norhave

E: jbitschn**[ta]**.jnj.com

Johan Verbeeck

E: jverbee2**[ta]**.jnj.com

Consumer R&D Leadership and Business Development Contacts

Global Consumer R&D

Josh Ghaim, Ph.D.

Chief Technology Offcer,

Johnson & Johnson Family of Consumer Companies

Fabiana Gargaro

VP, Global Femcare R&D Deployment (LATAM)

Consumer R&D Franchise Leaders

Consumer R&D Regional Leaders

Anna Prilutsky

VP, Global Baby R&D

Jonathan Miller

VP, Global Oral Care/Wound Care R&D

Jennifer Zhu

VP, Global Beauty R&D

Stephen Raven

VP, Global Self-Care and

R&D Deployment (EMEA)

Adam Ricciardone

VP, R&D Deployment (Asia Pacifc)

Mona Nair

VP, Global eCommerce New Initiatives & R&D

Deployment (North America)

Consumer External Innovation

John Bell

VP, External Innovation & Business Models

EARLY STAGE - J&J INNOVATION

Stephanie Robertson

Senior Director, Consumer Scientifc

Innovation (West US)

E: srober18**[ta]**.jnj.com

Stefanie Dhanda

Senior Director, Scientifc Innovation,

Consumer (East US)

E: sdhanda**[ta]**.jnj.com

Elena Fernandez-Kleinlein

Senior Director, Scientifc Innovation,

Consumer (Europe)

E: efernkle**[ta]**.jnj.com

Tyrone Mao

Senior Director, Scientifc Innovation,

Consumer (Asia Pacifc)

E: tmao2**[ta]**.jnj.com

Consumer Business Development

Peter Kerrane

Worldwide VP, Strategy & Business Development

E: pkerrane**[ta]**.jnj.com

Brian Shuster

VP, Consumer Business Development

E: bshuster**[ta]**.jnj.com

Medical Devices R&D Leadership and Business Development Contacts

Medical Devices R&D

Peter Shen, Ph.D.

Global Head of Research & Development,

Johnson & Johnson Medical Devices Companies

Medical Devices Business Development

Susan Morano

Global Head of Business Development,

Johnson & Johnson Medical Devices Companies

Medical Devices R&D Heads

Euan Thomson

Global Head, Digital Technologies

and Advanced Innovation

Beth McCombs

Vice President, R&D, Ethicon

Rob Laird

Vice President, R&D, DePuy Synthes

Avi Shalgi

Vice President, R&D, Cardiovascular

& Specialty Solutionst

Jennifer Kozac

VP, Business Development, New Growth Platforms

E: jkozak**[ta]**.jnj.com

Noam Krantz

WW VP, Business Development, Ethicon

E: nkrantz**[ta]**.jnj.com

Christine Knoblauch

VP, Business Development, DePuy Synthes

E: cknobla2**[ta]**.jnj.com

Biren Mehta

VP, Business Development, Cardiovascular

& Specialty Solutions

E: bmehta5**[ta]**.jnj.com

Vision R&D Leadership and Business Development Contacts

Vision R&D

Xiao-Yu Song, M.D., Ph.D.

Global Head of Research & Development,

Johnson & Johnson Vision

Vision Business Development

JD Moore

Global Head of Business Development,

Johnson & Johnson Vision

Troy Wu

Senior Director, Business Development, Surgical

E: twu29**[ta]**.jnj.com

Matthew Rieke

Senior Director, Business Development, Surgical

E: mrieke**[ta]**.jnj.com

Tonja Danowski

VP, Business Development, Vision Care

E: tcurtis2**[ta]**.jnj.com

Vision R&D Heads

David Turner

Head of R&D, Contact Lens Platform

Griffth Altmann

Head of R&D, Surgical Instrumentation

Manohar Raheja

Head of R&D, Ophthalmic Implant Platform

Randall Pugh

Head of Smart Device Technology

Vision External Innovation

EARLY STAGE - J&J INNOVATION

Leonard Borrmann

Head of External Innovation (West US)

E: lborrman**[ta]**.jnj.com

Hassan Chaouk

Director of External Innovation (East US)

E: hchaouk**[ta]**.jnj.com

EMAIL US:

jnjinnovation**[ta]**.jnj.com

FOLLOW US ON TWITTER:

**[ta]JNJInnovation

VISIT OUR WEBSITE FOR MORE INFORMATION:

HTTP://**jinnovation.com

HTTP://**bs.jnjinnovation.com

APPLY FOR A CHALLENGE:

HTTP://**nnovation.com/challenges

Johnson & Johnson Innovation, LLC ***